<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:chebi fb="3" ids="44915">Propofol</z:chebi> is commonly used as an <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> during catheter ablation </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001662'>Bradycardia</z:hpo> and termination of <z:hpo ids='HP_0004755'>supraventricular tachycardia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e>) under <z:chebi fb="3" ids="44915">propofol</z:chebi> are reported </plain></SENT>
<SENT sid="2" pm="."><plain>Ketamine is used for cardiac catheterization procedures and increases heart rate and blood pressure </plain></SENT>
<SENT sid="3" pm="."><plain>Our study aimed to determine the effects of propopfol and ketamine on atrial electrophysiology.METHODS AND RESULTS: Thirty-one patients undergoing electrophysiological study prior to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> ablation were enrolled </plain></SENT>
<SENT sid="4" pm="."><plain>Patients received a combination of <z:chebi fb="3" ids="44915">propofol</z:chebi>/midazolam (n = 10), ketamine/midazolam (n = 9), or midazolam alone (n = 12) </plain></SENT>
<SENT sid="5" pm="."><plain>Electrophysiological study was performed before and after administration of the <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> agents </plain></SENT>
<SENT sid="6" pm="."><plain>Blood pressure, corrected sinus node recovery time, <z:e sem="disease" ids="C0264907" disease_type="Disease or Syndrome" abbrv="">Wenckebach</z:e> cycle length, and atrial conduction time were measured </plain></SENT>
<SENT sid="7" pm="."><plain>We found a significant increase in heart rate, systolic, and diastolic blood pressure and a significant shortening of atrial conduction time after administration of ketamine compared with <z:chebi fb="3" ids="44915">propofol</z:chebi> and the control </plain></SENT>
<SENT sid="8" pm="."><plain>Results for ketamine, <z:chebi fb="3" ids="44915">propofol</z:chebi> and the control, respectively: mean (SD) change in heart rate was 12.4 (8.3), -1.4 (8), and 1 (7.5) b.p.m </plain></SENT>
<SENT sid="9" pm="."><plain>(P = 0.002); mean (SD) change in systolic blood pressure was 19.2 (8.1), -22 (9), and 0.1 (5.7) mmHg (P &lt; 0.001); mean (SD) change in diastolic blood pressure was 6.6 (9.7), -7.8 (2.9), and 2.3 (4.5) mmHg (P = 0.001); and mean (SD) change in atrial conduction time was -13.7 (16.4), 4.5 (11.1), and -0.3 (3.8) ms (P = 0.008) </plain></SENT>
<SENT sid="10" pm="."><plain>No significant affection of sinus node or antrioventricular node function was seen.CONCLUSION: Our results show stimulatory effects of ketamine on heart rate, atrial conduction, and blood pressure </plain></SENT>
<SENT sid="11" pm="."><plain>Ketamine, therefore, may be beneficial in patients with pre-existing <z:hpo ids='HP_0002615'>hypotension</z:hpo> and <z:hpo ids='HP_0001662'>bradycardia</z:hpo> </plain></SENT>
</text></document>